Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies.
about
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tyrosine Kinase Inhibitors in ...... ting Proof-of-Concept Studies.
@en
type
label
Tyrosine Kinase Inhibitors in ...... ting Proof-of-Concept Studies.
@en
prefLabel
Tyrosine Kinase Inhibitors in ...... ting Proof-of-Concept Studies.
@en
P2860
P356
P1476
Tyrosine Kinase Inhibitors in ...... ting Proof-of-Concept Studies.
@en
P2093
Jessica Gordon
Robert Spiera
P2860
P304
P356
10.1155/2011/842181
P577
2011-10-13T00:00:00Z